南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

ADAMDEC-1通过与ACTN4相互作用并调节PTEN-PI3K/AKT信号通路,促进动脉粥样硬化病变进展。

ADAMDEC-1 promotes atherosclerosis progression by interacting with ACTN4 and modulating the PTEN-PI3K/AKT signaling axis

Zhang Yanmei, Dai Chengwei, Luo Lianxin, Gao Yu, Wang Xiaochen

Journal:MOLECULAR AND CELLULAR BIOCHEMISTRY

IF:4.7

DOI:10.1007/s11010-026-05702-y

PMID:

Published:2026-08-20

research field:神经科学分子生理学细胞生物学膜运输胞吐与内吞作用

Abstract

Atherosclerosis (AS) is a chronic vascular disease process that accounts for a large share of cardiovascular morbidity, and substantial risk remains even when currently available therapies are used. ADAMDEC-1, also referred to as ADAM-like decysin-1, has mainly been discussed in mucosal and intestinal immune regulation. Its involvement in vascular injury has not been adequately defined. This study was designed to determine whether ADAMDEC-1 contributes to AS and to map the signaling mechanism responsible for this effect. ADAMDEC-1 was suppressed in an experimental AS mouse model by AAV-mediated shRNA delivery. In parallel, cultured human vascular smooth muscle cells (HVSMCs) were stimulated with oxidized low-density lipoprotein (ox-LDL) to reproduce pro-atherosclerotic cellular stress. Protein expression, protein interaction, subcellular localization, cell proliferative capacity, migration, and cell-cycle changes were assessed using Western blotting, IP-MS, Co-IP, immunofluorescence, CCK-8, Transwell, scratch wound-healing, and flow-cytometry assays. ADAMDEC-1 knockdown reduced aortic lesion burden and was accompanied by increased HDL and decreased LDL and triglyceride levels in AS mice. Qualitative IP-MS screening identified ACTN4 as a candidate ADAMDEC-1-interacting protein, and their association was supported by Co-IP. Ox-LDL treatment also increased the cellular colocalization of ADAMDEC-1 and ACTN4. In aortic tissues, ADAMDEC-1 knockdown was accompanied by reduced ACTN4 abundance, restored PTEN expression, and attenuated PI3K/AKT phosphorylation. In HVSMCs, ACTN4 knockdown reduced ox-LDL-induced cell proliferative capacity, migration, cell-cycle redistribution, and expression of PCNA, MMP2, and MMP9. These findings indicate that ADAMDEC-1 contributes to experimental AS and is associated with ACTN4 and PTEN/PI3K/AKT signaling. ACTN4 is required for the full ox-LDL-induced phenotype in HVSMCs.

本文使用的Yeasen产品

购物车
客服
转染试用